Quick Answer
BIOMERICA INC reported Cash and Equivalents of $2.40 million for fiscal year 2025.
BIOMERICA INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.40M | -42.5% |
| 2024 | $4.17M | -57.1% |
| 2023 | $9.72M | +64.3% |
| 2022 | $5.92M | +40.9% |
| 2021 | $4.20M | -51.4% |
| 2020 | $8.64M | +1158.2% |
| 2019 | $686.8K | -43.0% |
| 2018 | $1.20M | -1.7% |
| 2017 | $1.23M | -35.1% |
| 2016 | $1.89M | +73.6% |
| 2015 | $1.09M | -27.9% |
| 2014 | $1.51M | -38.9% |
| 2013 | $2.47M | +129.2% |
| 2012 | $1.08M | +8.9% |
| 2011 | $989.3K | -6.2% |
| 2010 | $1.06M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $2.54M | +7.2% | -16.7% |
| August 31, 2025 | $3.05M | +8.3% | +27.3% |
| May 31, 2025 | $2.40M | -42.5% | -21.6% |
| February 28, 2025 | $3.06M | -42.5% | +28.9% |
| November 30, 2024 | $2.37M | -66.8% | -15.9% |
| August 31, 2024 | $2.82M | -64.7% | -32.4% |
| May 31, 2024 | $4.17M | -57.1% | -21.6% |
| February 29, 2024 | $5.32M | +59.0% | -25.4% |
- BIOMERICA INC showed a decrease of -42.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, BIOMERICA INC’s cash and equivalents has grown by 127.3% (from $1.06 million to $2.40 million).
- The most recent figure is from BIOMERICA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: